| C反应蛋白检测指导新生儿感染用药的研究 |
| |
| 引用本文： | 邵志英,张彬彬,朱敏蓉,王留娣.C反应蛋白检测指导新生儿感染用药的研究[J].现代中西医结合杂志,2010,19(14):1704-1705. |
| |
| 作者姓名： | 邵志英 张彬彬 朱敏蓉 王留娣 |
| |
| 作者单位： | 上海市浦东新区妇幼保健院,上海,200206 |
| |
| 摘 要： | 目的评价C反应蛋白(CRP)作为新生儿细菌感染停药指标的临床安全性。方法符合病例入选标准的150例新生儿根据出生后检测的CRP值分为无感染组42例和感染组108例。感染组又分为CRP指导组54例和7 d治疗组54例。CRP指导组根据每天测得的CRP作为停用抗生素的指标;7 d治疗组应用抗生素至少7 d,待临床症状消失和CRP8mg/L后停药。结果无感染组2.38%的患者需再次接受抗生素治疗,感染组无患者需再次接受抗生素治疗者。抗生素疗程:无感染组为3 d,CRP指导组为4~11(4.6±1.2)d,7 d治疗组为7~14(9.8±1.6)d;3组之间抗生素疗程均有显著性差异(P均0.01);而再感染发生率无显著性差异(P0.05)。结论CRP可作为新生儿细菌感染停用抗生素的安全有效指标,可明显缩短抗生素疗程,而不增加感染复发率。
|
| 关 键 词： | CRP 新生儿 细菌感染 抗生素 |
Study of C reaction protein detection guiding medication for infectious diseases of neonate |
| |
| Shao Zhiying,Zhang Binbin,Zhu Minrong,Wang Liudi.Study of C reaction protein detection guiding medication for infectious diseases of neonate[J].Modern Journal of Integrated Chinese Traditional and Western Medicine,2010,19(14):1704-1705. |
| |
| Authors: | Shao Zhiying Zhang Binbin Zhu Minrong Wang Liudi |
| |
| Institution: | Shao Zhiying,Zhang Binbin,Zhu Minrong,Wang Liudi(Pudong Newly-built District Maternal , Child Health Hospital of Shanghai City,Shanghai 200206,China) |
| |
| Abstract: | Objective It is to evaluate the clinical safety of C reaction protein(CRP) as drug withdrawal index in bacterial infection of neonate.Methods 150 neonates who were in line with selected standard were divided into free from infection group in which there was 42 cases and infection group in which there was 108 cases according to the CRP value detected.Infection group was divided into CRP guiding group in which there was 54 cases and seven day's treatment group in which there was 54 cases once again.The level ... |
| |
| Keywords: | CRP |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
